• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Bracco takes control of Acist

Article

Italian pharmaceutical maker Bracco has completed its acquisition of Acist, a start-up that manufactures contrast media injection systems. Bracco previously had a 12% stake in Acist, whose latest generation of injectors allows the automatic and

Italian pharmaceutical maker Bracco has completed its acquisition of Acist, a start-up that manufactures contrast media injection systems. Bracco previously had a 12% stake in Acist, whose latest generation of injectors allows the automatic and controlled administration of fluids during x-ray procedures. Acist has more than 500 systems installed worldwide and a 50% share of the U.S. cardiology injector market.

Related Videos
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Related Content
© 2024 MJH Life Sciences

All rights reserved.